HIMSS: Launch Stage 2 on schedule but extend attestation period

After multiple organizations have criticized the Meaningful Use program and called for delays, the Health Information and Management Systems Society (HIMSS) is recommending the same launch date for Stage 2 but a longer attestation period.

The organization suggests launching Stage 2 Meaningful Use on-schedule and extending Year 1 of the Meaningful Use Stage 2 attestation period through April 2015 and June 2015 for eligible hospitals (EHs) and eligible providers (EPs), respectively. This would encompass 18 months in which EHs and EPs can attest to Meaningful Use requirements for one quarter.

Data from the more than 5,400 hospitals in the HIMSS Analytics database indicate clear challenges for eligible hospitals and tethered ambulatory care facilities preparing for Meaningful Use Stage 2.  These data show that up to 68 percent of eligible hospitals and 41 percent of tethered ambulatory facilities have purchased the necessary software to attest to the 2014 certification requirements, but there are concerns that many may still be waiting for the necessary upgrade to the certified version. 

HIMSS shared its position on extending the deadline for Meaningful Use Stage 2 attestation in an Aug. 15 letter to Department of Health and Human Services Secretary Kathleen Sebelius; Centers for Medicare and Medicaid Services Administrator Marilyn Tavenner; and National Coordinator for Health IT Farzad Mostashari, MD, ScM.

“In our Call to Action, HIMSS asks the healthcare community--providers, hospitals and vendors--to come together in their execution plans for the 2014 certification process and implementation of 2014 certified products. We have recommended an extra six months to achieve Year 1 of Meaningful Use Stage 2, which is a brief amount of time when considering our ultimate and joint goal of successful implementation of health IT to support care coordination and healthcare transformation,” said Carla Smith, MA, CNM, FHIMSS, Executive Vice President, HIMSS.

Read the HIMSS letter to Sebelius, Tavenner and MostashariRead the HIMSS Call to Action statement.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.